The shorts are working hard to keep a lid on this.
The shorts are the ones that will be covering at several times the current price when the Becton Dickinson deal is finalized.
Almost 1,000,000 shares bought in the last ten minutes of trading today bodes well for tomorrow.
Read today's Yahoo news. Deal with Becton Dickinson to be finalized soon.
Research the company. Tremendous potential.
Follow on Twitter: @AmarantusBio .... 8,488 followers
Three more reasons:
18. Most undervalued stock in the market.
19. Members of the company's advisory board are reknown in the industry.
20. Gerald may well be "Bio-Tech C.E.O. of the Year for 2014".
Posted by JPetrolnc On the AMBS IHub Board:
01. corp funding landscape has turned to upside
02. Series D Preferred, past debts paid, 18 mo. financial runway
03. Dominion clearly has silent investors w/serious cash in hand
04. greater dilution risk now in check
05. Lympro will be proverbial 'ticket out of jail' for AMBS
06. BD Lympro test validation w/outstanding results
07. looming BD Lympro Partnership/Licensing deal
08. current MANF orphan indications = 7 + counting
09. more orphan indications to be revealed
10. greatly increased potential for several MANF Licensing deals
11. RP and DB Licensing candidates now in major public focus
12. new DB orphan status data to set stage for game changer
13. potential Novartis MANF DB Partnership/Licensing deal
14. potential MANF RP trial Pharma Partner
15. pending MANF TBI trial data
16. L-Dopa-Induced Dyskinesia in licensing agreement disclosure
17. new analyst coverage